One of India's fastest-growing discount brokers just launched a rights issue — and it comes with a twist that is unusual in Indian markets. 5paisa Capital Limited has announced a rights issue at ₹300 per share, which is actually priced at a slight premium to its market price of ₹293.90 — a rare occurrence that makes this capital raise particularly noteworthy. Here is everything you need to know before deciding whether to subscribe, renounce, or ignore.
📋 5paisa Capital Rights Issue — Complete Details
|
Parameter |
Details |
|
Company |
5paisa Capital Limited |
|
BSE Code / NSE Symbol |
540776 / 5PAISA |
|
Face Value |
₹10 per share |
|
Issue Price |
₹300 per share (Premium: ₹290 per share) |
|
Issue Size |
₹468.82 Crore (1,56,27,419 equity shares) |
|
Entitlement Ratio |
1:2 — 1 Rights Share for every 2 fully paid equity shares held |
|
Record Date |
Monday, March 17, 2026 |
|
Rights Issue Open Date |
Friday, March 27, 2026 |
|
Rights Issue Close Date |
Friday, April 10, 2026 |
|
RE (Rights Entitlement) Trading Start |
March 27, 2026 |
|
RE Trading Last Date |
Monday, April 7, 2026 |
|
Allotment Date (Tentative) |
Sunday, April 13, 2026 |
|
Refund / Credit Date |
On or after April 13, 2026 |
|
Pre-Issue Equity Shares |
3,12,54,838 shares |
|
Post-Issue Equity (Full Subscription) |
4,68,82,257 shares |
|
Dilution |
~33.3% on post-issue basis |
|
Letter of Offer Filed |
March 12, 2026 with SEBI, BSE & NSE |
|
Use of Proceeds |
Debt repayment / prepayment (₹15 Crore) + general corporate purposes + capital base strengthening |
|
CMP (March 17, 2026) |
₹293.90 — up 0.46% | Market Cap: ~₹918 Crore |
|
52-Week Range |
₹205.50 – ₹381.85 |
|
Discount to CMP |
₹300 issue price vs ₹293.90 CMP — issue price at ~2% PREMIUM to market price (rare) |
🏢 About 5paisa Capital :-
5paisa Capital Limited, incorporated in July 2007, is a SEBI-registered technology-driven discount brokerage firm originally incubated within the IIFL Group. Headquartered at Thane, Maharashtra, it offers a full suite of retail financial services — equity and derivatives trading, mutual fund distribution, IPO investments, bonds, commodities, currency trading, and advisory services — all through its digital app and web platform.
💰 Why is 5paisa Raising ₹468.82 Crore? Use of Proceeds
The company plans to use the rights issue proceeds for three purposes:
- Debt repayment / prepayment: ₹15 crore earmarked specifically for repaying or prepaying outstanding borrowings and accrued interest — reducing finance costs and improving balance sheet quality
- Capital base strengthening: A significant portion directed toward augmenting the company's net worth — essential for an NBFC and brokerage to meet regulatory capital requirements, expand margin lending (MTF), and scale operations
- General corporate purposes: Remaining proceeds for technology investment, customer acquisition, platform upgrades, and working capital — supporting 5paisa's continued digital platform expansion
The context: 5paisa's Q3 FY26 revenue fell 7.03% YoY and net profit dropped 23.60% YoY — driven by weak market conditions in the October–December 2025 quarter and compressed broking revenues sector-wide. The rights issue is therefore partly a defensive move to shore up the balance sheet during a challenging period, and partly an offensive one to fund growth as market conditions improve.
📊 5paisa Capital Financials — The Numbers
|
Metric |
FY 2024 |
Q3 FY26 (Oct–Dec 2025) |
YoY Change Q3 |
|
Revenue (₹ Million) |
3,947 |
793 |
–7.03% YoY |
|
Net Profit (₹ Million) |
544 |
123 |
–23.60% YoY |
|
PAT Margin |
13.8% |
15.5% |
Margin resilient |
|
ADTO (Average Daily Turnover) |
— |
₹3.31 Trillion |
+24% QoQ (strong) |
|
Customer Base |
— |
50.8 Lakh |
Growing |
|
Revenue Growth (FY24 YoY) |
16.8% |
— |
Strong full-year |
|
Net Profit Growth (FY24 YoY) |
25.0% |
— |
Strong full-year |
The contrast between FY24 full-year performance (revenue +16.8%, PAT +25%) and Q3 FY26 (revenue –7%, PAT –23.6%) reflects the broader broking industry headwind — SEBI's F&O regulatory tightening from October 2024 hit volumes across all discount brokers. However, 5paisa's ADTO growing 24% QoQ in Q3 FY26 signals a volume recovery in progress. The 50.8 lakh customer base remains a meaningful and growing asset.
📈 The Unusual Twist — Rights Issue at a PREMIUM to Market Price
Most rights issues are priced at a discount to the current market price — giving existing shareholders an incentive to subscribe. 5paisa's rights issue at ₹300 per share is priced at approximately 2% above the CMP of ₹293.90 on March 17, 2026. This is an unusual and noteworthy structure.
- What it means: Existing shareholders are being asked to pay more than the current market price for new shares — no built-in discount incentive
- Why the company still chose ₹300: The price was fixed on March 11, 2026 when the stock may have been trading higher. By March 17 (record date), the stock had dipped to ₹293.90 — creating an inadvertent premium
- Implication for shareholders: If the stock stays below ₹300 through the subscription period (March 27 – April 10), rational investors would prefer to buy from the open market rather than subscribe to the rights issue
- RE trading opportunity: Shareholders who do not wish to subscribe can sell their Rights Entitlements (RE) on BSE/NSE from March 27 to April 7, 2026 — potentially recovering some value from their entitlement
📱 How to Apply for 5paisa Rights Issue
- Step 1 — Check eligibility: You must have held 5paisa Capital shares in your Demat account as of the Record Date of March 17, 2026, to receive Rights Entitlements (REs) in your Demat account
- Step 2 — Via UPI (Online — Fastest): Log in to your broker app | Go to Rights Issue section | Search '5paisa Capital' | Enter quantity (multiples of 1 RE = 1 rights share at ₹300) | Enter UPI ID | Approve mandate within 30 minutes
- Step 3 — Via ASBA (Net Banking): Log in to your bank's net banking | Navigate to ASBA / Rights Issue | Fill in application number from your Demat account, quantity, and price | Submit — funds blocked until allotment
- Step 4 — Via Offline Form: Download the Application Form from SEBI website, fill in details, submit to your broker or Designated Bank Branch along with a cheque or DD
- Step 5 — RE Trading (Renunciation): If you do NOT want to subscribe, sell your Rights Entitlement (RE) on BSE/NSE before April 7, 2026 — buyers of REs can apply for the rights issue in your place
- Allotment: Tentatively April 13, 2026 — check via MUFG Intime website or BSE/NSE corporate actions page
FAQs — 5paisa Capital Rights Issue 2026
Q1. What is the 5paisa Capital rights issue price and ratio?
- 5paisa Capital's rights issue is priced at ₹300 per share (face value ₹10, premium ₹290). The entitlement ratio is 1:2 — eligible shareholders receive 1 rights share for every 2 fully paid-up equity shares held as of the Record Date of March 17, 2026. The issue size is ₹468.82 crore (1,56,27,419 shares).
Q2. What is the record date for the 5paisa rights issue?
- The record date for the 5paisa Capital rights issue is Monday, March 17, 2026. Shareholders who held 5paisa shares in their Demat account on this date will receive Rights Entitlements (REs) in their Demat accounts, which can be used to subscribe to new shares or sold to other investors on BSE/NSE.
Q3. When does the 5paisa rights issue open and close?
- The 5paisa Capital rights issue subscription opens on Friday, March 27, 2026, and closes on Friday, April 10, 2026. Rights Entitlement (RE) trading on BSE/NSE begins March 27, 2026, and the last date for RE trading is Monday, April 7, 2026. Tentative allotment date is April 13, 2026.
Q4. Can I sell my rights entitlement instead of subscribing?
- Yes — this is an important feature. If you do not wish to subscribe to the rights issue (especially since it is priced at a premium to CMP), you can sell your Rights Entitlement (RE) on BSE or NSE during the RE trading window: March 27 to April 7, 2026. The buyer of your RE will then be able to apply for the rights shares in your place. This gives you a way to monetise your entitlement without actually investing fresh capital.
Q5. Is the rights issue priced at a discount or premium to the market price?
- Unusually, the 5paisa Capital rights issue at ₹300 per share is priced at a slight premium to the market price of ₹293.90 as of March 17, 2026. Most rights issues are priced at a 10–30% discount to market price to incentivise subscription. This premium pricing reduces the financial incentive for existing shareholders to subscribe — making RE trading (selling your entitlement) or open-market buying relatively more attractive alternatives.
Q6. How will 5paisa use the rights issue proceeds?
- 5paisa Capital intends to use the ₹468.82 crore raised through the rights issue for: (1) Debt repayment — ₹15 crore specifically earmarked for repaying outstanding borrowings and accrued interest. (2) Capital base strengthening — augmenting net worth to meet regulatory requirements, scale MTF and margin operations, and improve financial ratios. (3) General corporate purposes — technology upgrades, customer acquisition, working capital, and platform investment.
Q7. Should I subscribe to the 5paisa rights issue?
- This depends on your existing holding and view on the stock. Key considerations: (1) The rights issue is priced at a PREMIUM to CMP — you may be able to buy shares cheaper in the open market. (2) Post-issue dilution is 33.3% — existing EPS will fall unless revenues recover. (3) Q3 FY26 earnings were weak — near-term headwinds remain. (4) Long-term bullish case:
